Medical device company Alphatec (ATEC) has purchased all assets linked to the robotic-enabled minimally invasive (REMI) System from Fusion Robotics for a consideration of $55m.

Developed by spine experts, REMI is an intra-operative platform that incorporates navigation and robotics into spinal surgical procedures using either a 3D imaging scan or 2D fluoroscopic images of the patient.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

REMI has a small, table-mounted navigation system, which helps in positioning instrumentation and implants more accurately during surgery.

The integration of a robotic navigation system into ATEC’s procedural strategy is expected to enhance surgical predictability and decrease radiation exposure, as well as improve intra-operative precision.

ATEC chairman and CEO Pat Miles said: “ATEC’s intention is to further clinical distinction by integrating actionable information into the spine’s procedural workflow.

“With our SafeOp and EOS systems, we have demonstrated prowess in identifying informational technologies and know-how that can integrate information into spine surgery’s procedural workflow.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Meanwhile, ATEC has reported that its total revenue in the first quarter of this year is expected to increase by 52% to more than $108m.

The growth is mainly driven by the rise in surgical revenue growth by more than 53% and surgical volume by around 39%, compared to the same period last year.

Furthermore, the company expects total revenue in 2023 to be roughly $450m, fuelled by surgical revenue of $393m.

Fusion Robotics is a medical device company engaged in the research, development and commercialisation of robotics technologies for use in spinal surgeries.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact